Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Accelrys, Inc. Acquires Vialis AG

Published: Sunday, February 10, 2013
Last Updated: Sunday, February 10, 2013
Bookmark and Share
Accelrys Strengthens Leadership Position in Laboratory Informatics Market

Accelrys, Inc.  is solidifying its market leadership in the laboratory informatics space with the acquisition of its long-time partner Vialis AG, a leading systems integrator based in Liestal, Switzerland serving the pharmaceutical, biotechnology, chemicals, and agro-science industries. Vialis' deep experience implementing and supporting paperless laboratory solutions further strengthens Accelrys' position in the laboratory informatics software market and expands the company's capabilities in the downstream analytical development, quality control, and quality assurance and manufacturing areas.

Under terms of the deal, Accelrys has purchased all of Vialis' outstanding stock for approximately $5 million in cash. The acquisition includes potential for additional incentive consideration of up to approximately $5 million in cash, contingent upon meeting specified growth objectives over the next three years.

"With demonstrated success in improving laboratory operations by integrating core software systems critical to improving innovation – including electronic laboratory notebooks, laboratory execution systems, and laboratory information management systems – Vialis brings key domain and delivery expertise to Accelrys, and we welcome them to our team," said Accelrys President and CEO Max Carnecchia. "This acquisition is a natural complement to our two most recent software acquisitions of Velquest and Aegis Corp., furthering our strategy to deliver software solutions that optimize the laboratory-to-commercialization value chain."

In addition to its systems integration services, Vialis' business process consultancy delivers process improvements in lab data management. Employing a proprietary approach to analyzing existing lab processes, Vialis' business process consultancy services help customers optimize efficiency, enhance quality by design efforts, increase compliance, maximize knowledge re- use and reduce cycle times.

The entire Vialis team is joining Accelrys. The team will be primarily focused on the recently announced Accelrys Process Management and Compliance Suite, which is designed specifically to enhance product and process insight, facilitate collaboration and streamline product development from research through late-stage quality control and manufacturing. The suite includes the Accelrys Electronic Laboratory Notebook, Accelrys Laboratory Execution System, Accelrys Electronic Batch Records, Accelrys Enterprise Platform and the Accelrys Discoverant solution recently acquired from Aegis.

"As a long-standing partner, we share Accelrys' vision of transforming the innovation lifecycle by delivering paperless laboratory solutions that enhance our customers' abilities to meet the operational challenges that are slowing scientific innovation," said Vialis CEO Ulf Fuchslueger, PhD. "Importantly, we share closely aligned go-to-market approaches and we believe this transition will bring significant leverage to our customers and partners."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Dassault Systèmes and Accelrys to Join Forces
Delivering Scientific Innovation in the Age of Experience
Friday, January 31, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Accelrys BioRails 4.5 and Accelrys Morphit 3.0 accelerate assay pipelines, improve cascade management and enhance collaborative decision-making in discovery biology.
Tuesday, November 19, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD
Saturday, April 06, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
German Cancer Research Center Selects Contur ELN from Accelrys
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).
Friday, December 28, 2012
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
Aquavit to utilize Accelrys Enterprise Platform to develop advanced medical software
Sunday, November 11, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos